| 000 | 01918 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515060442.0 | ||
| 264 | 0 | _c20070503 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190601060496 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLim, Soon-Thye | |
| 245 | 0 | 0 |
_aA phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cFeb 2007 |
||
| 300 |
_a374-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoquinolines _xadministration & dosage |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFayad, L | |
| 700 | 1 | _aTulpule, A | |
| 700 | 1 | _aModiano, M | |
| 700 | 1 | _aCabanillas, F | |
| 700 | 1 | _aLaffranchi, B | |
| 700 | 1 | _aAllievi, C | |
| 700 | 1 | _aBernareggi, A | |
| 700 | 1 | _aLevine, Alexandra M | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 48 _gno. 2 _gp. 374-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190601060496 _zAvailable from publisher's website |
| 999 |
_c16883603 _d16883603 |
||